Perioperative management of the diabetic patient.
Diabetes mellitus is a significant global public health problem and is a major source of morbidity and mortality in the world today. Type 2 diabetes mellitus is the predominant form of diabetes worldwide and represents approximately 90% of all cases. There is an epidemic of type 2 diabetes mellitus in the world today in both developed and developing countries. Globally, it is expected that the number of people with diabetes will increase from the current 150 million to 220 million by the year 2010 and to 300 million by the year 2025. In addition, there has been an alarming increase in the incidence of type 2 diabetes in children and adolescents. It is therefore increasingly likely that diabetic patients will appear for dental and oral maxillofacial surgical treatment in both the office and ambulatory surgery clinic setting. Surgical stress often produces hyperglycemia in the perioperative period. Hyperglycemia has been shown to cause a significant increase in perioperative morbidity and mortality. It is the general consensus that strict glycemic control is beneficial and should be achieved for diabetic patients in the perioperative period. Preoperative, intraoperative, and postoperative management protocols for improved perioperative glycemic control of both type 1 and type 2 diabetics are presented.
Bergman
Stewart A
SA
Department of Oral Maxillofacial Surgery, Baltimore College of Dental Surgery, University of Maryland, Baltimore, MD 21201, USA. sab001@dental.umaryland.edu
D001786:Blood Glucose / Q000032:analysis; D017742:Dental Care for Chronically Ill; D048909:Diabetes Complications / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000628:therapy; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D019647:Oral Surgical Procedures; D019990:Perioperative Care
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents